Concepedia

Kyle Elrod

KE

Statistics

Publications

19

Citations

727

H-Index

14

Active since

1997

Affiliations

Sunesis (United States)(Current)

Kyle Elrod is an author at Sunesis (United States) specializing in life sciences, enzyme inhibition, and pharmacology.

Publications per year

1997–2018

19

Publications

19

Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep

Kyle Elrod, William R. Moore, William M. Abraham et al. · American Journal of Respiratory and Critical Care Medicine · 1997 · 109 citations

, , +13

A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site11Edited by D. Rees

B.A. Katz, Kyle Elrod, Christine Luong et al. · Journal of Molecular Biology · 2001 · 76 citations · Full text

, , +16

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

B.A. Katz, Paul A. Sprengeler, Christine Luong et al. · Chemistry & Biology · 2001 · 67 citations · Full text

, , +10

High-Throughput Screening of Enzyme Inhibitors: Automatic Determination of Tight-Binding Inhibition Constants

Petr Kuzmič, Steve Sideris, Lynne Cregar et al. · Analytical Biochemistry · 2000 · 64 citations

, , +17

High-Throughput Screening of Enzyme Inhibitors: Simultaneous Determination of Tight-Binding Inhibition Constants and Enzyme Concentration

Petr Kuzmič, Kyle Elrod, Lynne Cregar et al. · Analytical Biochemistry · 2000 · 60 citations

, , +16

1–5 of 19